vaccin
respiratori
viral
diseas
standard
practic
commerci
poultri
oper
live
kill
vaccin
administ
poultri
live
vaccin
commonli
use
varieti
pathogen
effect
mass
appli
rel
econom
gener
live
vaccin
induc
local
cellmedi
immun
provid
broader
protect
respons
kill
vaccin
wherea
kill
vaccin
primarili
induc
humor
immun
tend
antigenspecif
durat
immun
achiev
follow
live
vaccin
administr
depend
age
type
bird
level
matern
immun
diseas
target
vaccin
immunogen
vaccin
method
vaccin
applic
number
interv
booster
virul
similar
field
challeng
viru
interv
vaccin
challeng
immunocompet
host
avian
coronaviru
infecti
bronchiti
viru
ibv
upper
respiratori
tract
viral
pathogen
poultri
lead
reduc
weight
gain
feed
effici
drop
egg
product
egg
qualiti
stunt
growth
secondari
bacteri
infect
result
airsaccul
viru
initi
replic
upper
respiratori
tract
follow
system
replic
reproduct
tract
strain
caus
lesion
kidney
infect
bird
may
exhibit
nasal
discharg
cough
sneez
tracheal
rale
diseas
prevent
vaccin
live
vaccin
commonli
use
induc
local
immun
protect
live
vaccin
gener
administ
young
bird
achiev
earli
protect
layer
breeder
also
boost
either
live
inactiv
vaccin
vari
base
similar
circul
field
virus
newcastl
diseas
nd
caus
virul
strain
avian
paramyxoviru
type
recent
reclassifi
avian
avulaviru
depend
strain
viru
clinic
sign
nd
infect
may
absent
may
involv
depress
inappet
respiratori
sign
nasal
discharg
sneez
cough
reduc
egg
product
egg
qualiti
neurolog
sign
torticolli
circl
paralysi
strain
newcastl
diseas
viru
ndv
character
lentogen
mesogen
velogen
accord
mean
death
time
embryo
lentogen
strain
low
pathogen
caus
mild
respiratori
enter
infect
follow
mesogen
strain
velogen
isol
highli
pathogen
often
caus
neurolog
sign
mortal
vaccin
regim
ndv
vari
may
util
combin
live
inactiv
virusvector
vaccin
unit
state
wide
use
tradit
vaccin
strain
compris
lentogen
viru
clone
strain
lasota
strain
infecti
laryngotrach
ilt
respiratori
diseas
poultri
caus
gallid
alphaherpesviru
econom
import
worldwid
clinic
manifest
ilt
includ
increas
mortal
reduc
egg
product
decreas
bodi
weight
gain
conjunct
tracheiti
expector
bloodi
mucu
sever
case
depress
sever
dyspnea
suscept
respiratori
pathogen
live
vaccin
ilt
viru
iltv
may
chicken
embryo
origin
ceo
tissu
cultur
origin
tco
passag
multipl
time
egg
tissu
cultur
respect
although
recombin
vaccin
ilt
commerci
avail
ceo
vaccin
wide
use
vaccin
iltv
worldwid
need
protect
chicken
differ
viral
pathogen
earli
age
vaccin
program
typic
includ
multipl
vaccin
varieti
pathogen
sampl
vaccin
regim
differ
poultri
sector
review
merck
veterinari
manual
wwwmerckvetmanualcom
interv
vaccin
often
matter
week
howev
littl
inform
show
interv
vaccin
suffici
bird
develop
adequ
immun
protect
challeng
viru
literatur
show
sequenti
viral
infect
may
result
viral
interfer
one
viru
block
subsequ
infect
andor
replic
anoth
viru
host
unknown
whether
phenomenon
result
reduc
protect
serial
administ
attenu
live
vaccin
chicken
interestingli
report
simultan
administr
virus
chicken
turkey
result
viral
interfer
studi
investig
typic
commerci
vaccin
schedul
consist
combin
serial
administ
live
attenu
viral
respiratori
diseas
vaccin
affect
develop
longev
immun
protect
homolog
challeng
commerci
ibv
vaccin
merck
anim
health
summit
nj
usa
use
studi
vaccin
dilut
accord
manufactur
recommend
challeng
viru
use
ibv
prepar
median
embryo
infecti
dose
viru
titer
calcul
reed
muench
method
commerci
ndv
vaccin
merck
anim
health
summit
nj
usa
use
vaccin
challeng
reconstitut
follow
manufactur
instruct
sinc
mesogen
velogen
strain
ndv
requir
biosafeti
level
avail
laboratori
experiment
model
protect
ndv
involv
significantli
reduc
viru
titer
steril
immun
second
exposur
challeng
vaccin
viru
iltv
commerci
ceo
vaccin
merck
anim
health
summit
nj
usa
pathogen
iltv
georgia
broiler
strain
use
vaccin
challeng
respect
strain
propag
chicken
kidney
cell
obtain
specif
pathogenfre
spf
chicken
ceo
vaccin
prepar
follow
manufactur
recommend
inocul
median
tissu
cultur
infect
dose
confirm
titrat
virus
chicken
kidney
cell
previous
describ
specificpathogenfre
egg
obtain
day
incub
hatch
poultri
diagnost
research
center
athen
ga
chick
place
fresh
pine
shave
coloni
hous
pen
chick
vaccin
manufactur
recommend
dose
via
oculonas
rout
accord
follow
schedul
ibv
doa
ndv
week
age
woa
ibv
woa
iltv
woa
ndv
woa
iltv
woa
addit
control
group
vaccin
homolog
challeng
conduct
woa
necropsi
perform
five
day
postchalleng
dpc
challeng
bird
receiv
one
four
treatment
ibv
ndv
iltv
challeng
treatment
group
challeng
viru
per
time
point
follow
nonvaccin
nonchalleng
n
vaccin
nonchalleng
n
vaccin
challeng
n
nonvaccin
challeng
n
ibvchalleng
bird
receiv
per
bird
intranas
ndvchalleng
bird
receiv
ndv
vaccin
intranas
reconstitut
accord
manufactur
protocol
iltvchalleng
bird
receiv
pathogen
strain
dose
per
bird
split
equal
eyedrop
intranas
rout
ibv
ndv
challeng
bird
observ
dpc
respiratori
sign
previous
describ
absent
mild
moder
sever
iltv
challeng
bird
observ
dpc
dyspnea
conjunct
depress
mortal
describ
previous
choanal
cleft
ibv
ndvchalleng
control
bird
dpc
trachea
iltvchalleng
control
bird
dpc
swab
viru
detect
swab
store
pb
woa
tear
collect
ad
granul
nacl
eye
blood
collect
wing
cardiac
punctur
ad
microcentrifug
tube
collect
serum
antibodi
detect
bird
human
euthan
eyelid
harderian
gland
hg
thymu
liver
spleen
cecal
tonsil
bursa
fabriciu
collect
store
viru
detect
neutral
buffer
formalin
trachea
remov
one
section
place
neutral
buffer
formalin
remain
portion
trachea
submerg
tissu
cultur
media
ciliostasi
test
describ
procedur
approv
univers
georgia
institut
anim
care
use
committe
aup
ciliostasi
test
perform
harvest
trachea
collect
cell
cultur
media
dulbecco
modifi
eagl
medium
trachea
five
tracheal
ring
measur
approxim
mm
thick
cut
repres
proxim
middl
distal
portion
cilia
activ
observ
use
invert
microscop
olympu
center
valley
pa
usa
score
system
follow
cilia
beat
cilia
beat
cilia
beat
cilia
beat
cilia
beat
previous
describ
maximum
possibl
score
trachea
tracheal
ring
score
three
individu
averag
total
score
trachea
calcul
ciliostasi
protect
score
group
determin
follow
formula
total
individu
score
group
number
individu
group
score
consid
protect
section
trachea
fix
neutral
buffer
formalin
process
embed
paraffin
section
cut
hematoxylin
eosin
stain
ibv
lesion
epitheli
hyperplasia
lymphocyt
infiltr
epitheli
decili
score
trachea
score
determin
follow
normal
focal
multifoc
diffus
describ
previous
ndv
lesion
descript
analysi
perform
iltv
lesion
microscop
lesion
score
scale
normal
sever
describ
previous
ibv
ndv
detect
viral
rna
extract
pb
swab
conduct
use
viral
isol
kit
thermo
fisher
waltham
usa
deep
well
magnet
particl
processor
thermo
scientif
waltham
usa
accord
manufactur
instruct
quantit
revers
transcript
polymeras
chain
reaction
qrtpcr
perform
agpathidtm
onestep
rtpcr
kit
thermo
fisher
waltham
usa
follow
manufactur
protocol
reaction
mixtur
contain
rtpcr
buffer
primer
probe
rtpcr
enzym
mix
viral
rna
qrtpcr
reaction
run
appli
fast
realtim
pcr
system
life
technolog
ltd
carlsbad
ca
usa
follow
condit
one
cycl
min
min
follow
cycl
primer
probe
ibv
qrtpcr
previous
publish
compris
forward
primer
ttt
gag
cct
agc
revers
primer
atg
ttg
tca
ctg
tct
att
duallabel
probe
probe
cac
cag
aac
ctg
tca
cct
primer
probe
ndv
qrtpcr
previous
describ
compris
forward
primer
ndv
agt
gat
gtg
ctc
gga
cct
revers
primer
ndv
cct
gag
gag
agg
cat
ttg
duallabel
probe
ndv
famttc
tct
agc
agt
ggg
aca
gcc
primer
obtain
integr
dna
technolog
coralvil
ia
usa
taqman
probe
synthes
biosearch
technolog
novato
ca
usa
realtim
rtpcr
compon
thermocycl
paramet
previous
describ
data
express
averag
cycl
threshold
ct
valu
sampl
group
posit
ct
valu
base
limit
detect
test
associ
viru
detect
egg
qrtpcr
reaction
plate
includ
standard
curv
rna
extract
control
posit
control
ibv
isol
allanto
fluid
use
templat
standard
curv
neg
control
also
includ
plate
consist
pcr
reagent
rna
iltv
total
dna
extract
tracheal
swab
use
dna
extract
miniprep
kit
promega
madison
wi
usa
describ
previous
duplex
realtim
pcr
assay
amplifi
fragment
viral
gene
iltv
fragment
chicken
alpha
gene
perform
previous
describ
ibvspecif
igg
titer
detect
use
commerci
igg
enzymelink
immunosorb
assay
elisa
ibv
antibodi
test
kit
idexx
westbrook
usa
briefli
serum
sampl
store
dilut
procedur
perform
accord
manufactur
protocol
tear
ibvspecif
iga
detect
use
commerci
igg
elisa
ibv
antibodi
test
kit
idexx
westbrook
usa
briefli
tear
serial
dilut
twofold
pb
incub
duplic
well
overnight
wash
step
perform
use
pbstween
tween
plate
incub
h
monoclon
mous
antichicken
igabiot
clone
southern
biotech
birmingham
al
usa
follow
streptavidinhrp
southern
biotech
birmingham
al
usa
final
antibodi
detect
step
complet
accord
manufactur
instruct
endpoint
titer
determin
report
lowest
dilut
optic
densiti
od
record
nm
wavelength
least
three
standard
deviat
mean
control
well
incub
tear
sampl
data
well
pinpoint
color
chang
due
residu
substrat
air
bubbl
exclud
analysi
result
report
endpoint
titer
data
analyz
use
prism
softwar
graphpad
softwar
inc
la
jolla
ca
usa
wwwgraphpadcom
viral
load
data
oneway
analysi
varianc
anova
dunnet
posttest
use
compar
treatment
group
within
collect
period
data
analyz
use
test
dunn
posttest
compar
treatment
group
within
collect
period
signific
differ
determin
p
day
follow
challeng
ibv
vaccinatedchalleng
bird
significantli
lower
rna
load
compar
posit
control
collect
time
tissu
sampl
except
cecal
tonsil
woa
tabl
vaccin
control
ibv
rna
detect
collect
time
except
cecal
tonsil
woa
choanal
cleft
woa
ibv
load
neg
control
tissu
limit
detect
use
ct
valu
previous
report
collect
time
except
woa
hg
neg
control
clinic
sign
ibv
infect
measur
day
postchalleng
significantli
reduc
vaccinatedchalleng
bird
compar
posit
control
week
except
woa
trend
clinic
sign
score
numer
lower
among
vaccinatedchalleng
bird
tabl
clinic
sign
absent
nonchalleng
neg
vaccin
control
bird
sign
vaccinatedchalleng
bird
significantli
differ
sign
nonchalleng
control
histopatholog
examin
trachea
group
rang
within
normal
limit
focal
multifoc
minim
moder
lymphocyt
tracheiti
howev
moder
lymphocyt
infiltr
frequent
seen
posit
control
week
proport
vaccinatedchalleng
bird
decili
acut
tracheal
necrosi
significantli
reduc
compar
posit
control
differ
neg
vaccin
control
tabl
ciliostasi
defin
cessat
tracheal
ciliari
movement
measur
dpc
number
bird
posit
ciliostasi
ciliostasi
protect
score
calcul
group
figur
collect
time
vaccinatedchalleng
bird
protect
ciliostasi
score
posit
control
protect
score
nonchalleng
neg
control
vaccin
control
protect
score
collect
time
ibvspecif
igg
titer
measur
serum
collect
dpc
time
except
woa
vaccin
bird
nonchalleng
challeng
group
exhibit
significantli
higher
titer
compar
nonvaccin
bird
nonchalleng
challeng
group
figur
woa
titer
vaccin
bird
regardless
challeng
statu
significantli
higher
compar
posit
control
titer
vaccinatedchalleng
bird
significantli
differ
titer
vaccin
control
woa
vaccinatedchalleng
bird
significantli
higher
titer
compar
neg
control
vaccinatedchalleng
bird
significantli
higher
titer
time
ibvspecif
iga
titer
measur
tear
collect
dpc
woa
woa
titer
vaccinatedchalleng
bird
significantli
higher
compar
titer
nonchalleng
neg
control
figur
woa
vaccinatedchalleng
bird
show
significantli
lower
titer
compar
posit
control
addit
vaccinatedchalleng
bird
significantli
higher
titer
vaccinatedunchalleng
group
woa
signific
differ
detect
dpc
ndv
vaccinatedchalleng
bird
either
undetect
rna
load
significantli
lower
load
compar
posit
control
titer
collect
time
tissu
sampl
tabl
nonchalleng
neg
control
vaccin
control
neg
rna
viru
use
ct
valu
previous
report
clinic
sign
measur
dpc
signific
woa
posit
control
clinic
sign
posit
control
differ
treatment
group
tabl
signific
differ
clinic
sign
exist
vaccinatedchalleng
bird
nonchalleng
control
time
week
histopatholog
examin
trachea
within
normal
limit
reveal
focal
multifoc
minim
mild
lymphocyt
tracheiti
grouprel
differ
trachea
also
evalu
ciliostasi
group
exhibit
ciliostasi
ndvspecif
serum
igg
titer
vaccinatedchalleng
bird
vaccin
control
significantli
higher
titer
posit
neg
control
collect
time
figur
signific
differ
titer
vaccinatedchalleng
bird
vaccin
control
time
similarli
signific
differ
titer
detect
nonvaccinatedchalleng
neg
control
except
woa
titer
nonvaccinatedchalleng
control
significantli
higher
dpc
iltv
strain
vaccinatedchalleng
bird
significantli
lower
viral
dna
load
posit
control
collect
time
tissu
tabl
dna
load
trachea
hg
undetect
low
differ
significantli
dna
load
nonchalleng
neg
vaccin
control
neg
use
ct
valu
previous
report
conjunctiva
dna
load
vaccinatedchalleng
bird
significantli
higher
dna
load
nonchalleng
neg
vaccin
control
except
woa
signific
differ
detect
vaccinatedchalleng
bird
vaccin
control
clinic
sign
viral
dna
detect
challeng
bird
dpc
sign
posit
control
becom
sever
dpc
tracheal
viral
load
increas
tabl
clinic
sign
score
measur
dpc
significantli
reduc
vaccinatedchalleng
bird
compar
posit
control
collect
point
except
woa
clinic
sign
score
numer
reduc
neg
control
vaccin
control
clinic
sign
clinic
sign
vaccinatedchalleng
bird
significantli
differ
compar
control
except
woa
clinic
sign
score
significantli
higher
tracheal
histolog
examin
within
normal
limit
reveal
focal
diffus
minim
mild
lymphocyt
tracheiti
trachea
group
posit
control
week
respect
acut
focal
necrot
tracheiti
syncytia
intranuclear
inclus
figur
ciliostasi
observ
trachea
bird
group
iltvspecif
igg
titer
serum
collect
day
postchalleng
significantli
higher
vaccin
bird
challeng
nonchalleng
group
compar
posit
neg
control
figur
present
studi
demonstr
pullet
serial
administ
live
attenu
vaccin
ibv
ndv
iltv
protect
homolog
challeng
ibv
ndv
iltv
least
week
determin
challeng
viru
detect
clinic
sign
histopatholog
ciliostasi
day
challeng
addit
studi
show
age
vaccin
interv
vaccin
interfer
develop
immun
viru
consequ
protect
homolog
challeng
design
vaccin
protocol
repres
typic
vaccin
program
ibv
ndv
iltv
commerci
pullet
knowledg
live
vaccin
virus
persist
flock
unclear
whether
immun
induc
live
vaccin
could
compromis
viral
interfer
phenomenon
one
replic
viru
block
infect
andor
replic
anoth
viru
although
vaccin
present
studi
administ
interv
week
feasibl
viru
previou
immun
still
present
time
subsequ
vaccin
ibv
vaccin
detect
respiratori
tract
day
postvaccin
ibv
isol
tracheal
cloacal
swab
collect
point
lay
week
age
hen
virusneg
sever
week
follow
recoveri
inocul
one
day
age
fenti
et
al
report
chicken
vaccin
ndv
shed
vaccin
viru
day
postinocul
addit
studi
hugh
et
al
demonstr
intermitt
shed
trachea
iltvimmun
chicken
week
postvaccin
experiment
studi
sequenti
viru
infect
publish
fewer
yet
consid
context
poultri
viral
respiratori
pathogen
costahurtado
et
al
demonstr
chicken
turkey
serial
infect
mesogen
strain
ndv
highli
pathogen
avian
influenza
viru
hpaiv
day
apart
result
initi
decreas
follow
subsequ
increas
replic
second
viru
subsequ
studi
group
found
low
pathogen
avian
influenza
viru
given
day
lentogen
strain
ndv
show
viral
interfer
wherea
viral
interfer
observ
virus
given
simultan
measur
vaccin
viru
replic
present
studi
therefor
could
determin
whether
one
vaccin
viru
compromis
infect
replic
subsequ
vaccin
viru
howev
goal
determin
chicken
sequenti
vaccin
three
virus
protect
viral
replic
clinic
sign
follow
homolog
challeng
thu
regardless
viral
interfer
data
show
immun
individu
vaccin
virus
compromis
follow
sequenti
administr
multipl
live
attenu
vaccin
target
differ
viral
respiratori
tract
pathogen
detect
ibv
rna
cecal
tonsil
vaccinatednonchalleng
bird
woa
subsequ
time
indic
residu
vaccin
viru
rna
remain
cecal
tonsil
least
woa
follow
second
ibv
vaccin
ibv
isol
cecal
tonsil
week
postinfect
known
persist
sever
month
variou
intern
organ
ibv
rna
also
detect
nonchalleng
neg
control
hg
woa
absent
tissu
collect
neg
control
display
clinic
sign
ibv
infect
clear
detect
ibv
rna
sampl
hg
neg
control
bird
like
repres
crosscontamin
process
sampl
sinc
ibv
detect
tissu
tracheal
histopatholog
lesion
decili
posit
control
consist
previou
report
ibvinduc
histopatholog
confirm
presenc
ciliostasi
among
posit
control
expect
ibvvaccinatedchalleng
bird
protect
ciliostasi
european
pharmacopoeia
state
ciliostasi
use
evalu
ibv
vaccin
efficaci
lack
ciliostasi
would
indic
vaccin
efficaci
therefor
observ
confirm
ibvvaccin
bird
protect
homolog
challeng
observ
robust
ibvspecif
serum
igg
titer
vaccin
bird
consist
previou
studi
show
ibv
infect
stimul
humor
respons
chicken
circul
antibodi
titer
correl
resist
infect
therefor
presenc
ibvspecif
serum
igg
titer
indic
bird
expos
vaccin
challeng
viru
correl
measur
protect
lack
signific
titer
nonvaccinatedchalleng
bird
explain
earli
time
collect
postchalleng
orrburk
et
al
found
signific
chang
igg
serum
titer
detect
day
postinocul
orrburk
et
al
also
demonstr
lack
signific
ibvspecif
iga
titer
tear
day
primari
secondari
exposur
ibv
iga
titer
significantli
higher
day
primari
exposur
ibv
studi
ibvspecif
iga
titer
measur
tear
dpc
reveal
consist
trend
may
explain
earli
time
collect
postinfect
beyond
scope
studi
collect
sampl
dpc
product
ibvspecif
iga
tear
later
time
point
demonstr
differ
experi
tear
collect
dpc
experi
chicken
challeng
ibv
show
higher
trend
specif
iga
titer
compar
nonchalleng
control
decis
use
vaccin
ndv
challeng
base
biosecur
regul
lack
appropri
biosafeti
level
facil
need
challeng
mesogen
velogen
strain
ndv
sinc
use
lentogen
strain
ndv
challeng
viru
experiment
design
protect
primarili
base
significantli
reduc
viru
detect
day
challeng
measur
local
immun
prevent
viru
infect
andor
replic
presum
bird
protect
infect
lentogen
strain
ndv
would
also
show
level
protect
exposur
mesogen
velogen
strain
vaccin
bird
sampl
time
significantli
lower
challeng
viru
rna
compar
posit
control
group
indic
vaccin
bird
develop
local
immun
respons
inde
protect
wherea
nonvaccin
posit
control
lentogen
ndv
caus
mild
respiratori
enter
infect
surpris
respiratori
sign
histolog
chang
mild
absent
despit
presenc
viral
rna
observ
clinic
sign
ndv
infect
woa
posit
control
bird
show
mild
clinic
sign
woa
clinic
sign
diseas
observ
later
challeng
time
observ
consist
exist
knowledg
nd
tend
sever
younger
bird
lack
ciliostasi
observ
ndv
posit
control
contrast
previou
report
demonstr
ndv
caus
ciliostasi
tracheal
explant
butler
et
al
demonstr
ndv
caus
ciliostasi
within
day
infect
tracheal
explant
malo
et
al
report
follow
vaccin
onedayold
chick
lentogen
ndv
peak
ciliostasi
occur
dpv
wane
dpv
discrep
result
previou
studi
may
explain
use
differ
lentogen
ndv
strain
studi
lasota
previou
report
well
establish
lasota
vaccin
strain
virul
may
explain
ciliostasi
observ
lasotavaccin
chick
lasotainfect
tracheal
explant
wherea
ciliostasi
observ
studi
use
vaccin
robust
ndvspecif
circul
igg
antibodi
respons
develop
follow
ndv
vaccin
stay
elev
consist
prior
research
indic
antibodi
may
detect
one
year
bird
immun
multipl
time
ndv
except
woa
igg
titer
nonvaccinatedchalleng
bird
significantli
increas
compar
titer
neg
control
observ
surpris
given
ndvspecif
antibodi
detect
serum
day
exposur
iltvchalleng
bird
vaccin
prevent
challeng
viru
replic
trachea
hg
complet
block
viru
replic
conjunctiva
especi
woa
may
suggest
wane
local
immun
iltv
second
vaccin
woa
addit
proxim
conjunctiva
inocul
site
eyedrop
intranas
might
explain
local
immun
respons
abl
complet
block
viral
replic
conjunctiva
success
clear
viru
could
replic
hg
trachea
posit
control
nonvaccinatedchalleng
demonstr
histolog
evid
ilt
infect
trachea
though
posit
control
test
posit
ilt
dna
pcr
find
surpris
light
report
guy
et
al
illustr
histolog
detect
ilt
highli
specif
poorli
sensit
notabl
intranuclear
inclus
bodi
present
initi
infect
day
disappear
follow
epitheli
cell
necrosi
desquam
may
explain
observ
dpc
posit
control
woa
respect
histolog
evid
ilt
infect
despit
presenc
ilt
dna
trachea
absenc
ciliostasi
observ
vaccin
nonvaccin
iltvchalleng
bird
dpc
surpris
given
butler
et
al
found
strain
iltv
caus
ciliostasi
correl
virul
moreov
author
show
ciliostasi
rare
occur
day
sometim
even
day
inocul
addit
gerganov
surtmadzhiev
also
demonstr
ciliostasi
iltvinfect
tracheal
organ
cultur
day
postinfect
therefor
result
combin
previou
studi
indic
measur
ciliostasi
may
reliabl
marker
protect
iltv
infect
ciliostasi
iltv
infect
studi
may
need
evalu
later
time
postinocul
lack
signific
iltvspecif
serum
igg
titer
nonvaccin
posit
control
may
explain
earli
time
collect
postchalleng
iltvspecif
antibodi
becom
detect
dpi
peak
dpi
howev
worth
note
antibodi
titer
correl
protect
iltv
infect
igg
titer
robust
vaccin
bird
throughout
studi
support
previou
data
antibodi
may
detect
least
year
taken
togeth
data
indic
typic
pullet
vaccin
program
consist
serial
administ
live
attenu
vaccin
ibv
ndv
iltv
interfer
immun
respons
individu
vaccin
bird
adequ
protect
homolog
challeng
least
woa
inform
import
show
consecut
administ
live
attenu
vaccin
multipl
respiratori
pathogen
effect
vaccin
strategi
develop
protect
immun
diseas
agent
longliv
bird
